ImageneBio Shares Outstanding History (IMA)
ImageneBio reported 48.3M shares outstanding at the end of fiscal 2024.
View full ImageneBio company overviewImageneBio annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 48.3M | 0 | 0.00% |
| 2023 | 2023-12-31 | 48.3M | 12.0M | +33.10% |
| 2022 | 2022-12-31 | 36.3M | 282,459 | +0.79% |
| 2021 | 2021-12-31 | 36.0M | 32.9M | +1061.65% |
| 2020 | 2020-12-31 | 3.1M | — | — |
ImageneBio quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | 48.3M | 0 | 0.00% |
| Q1 2025 | 2025-03-31 | 48.3M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 48.3M | 0 | 0.00% |
| Q3 2024 | 2024-09-30 | 48.3M | 4.2M | +9.42% |
| Q2 2024 | 2024-06-30 | 48.3M | 6.0M | +14.09% |
| Q1 2024 | 2024-03-31 | 48.3M | 12.0M | +33.10% |
| Q4 2023 | 2023-12-31 | 48.3M | 12.0M | +33.10% |
| Q3 2023 | 2023-09-30 | 44.1M | 7.8M | +21.64% |
| Q2 2023 | 2023-06-30 | 42.3M | 6.0M | +16.68% |
| Q1 2023 | 2023-03-31 | 36.3M | 147,959 | +0.41% |
| Q4 2022 | 2022-12-31 | 36.3M | 282,459 | +0.79% |
| Q3 2022 | 2022-09-30 | 36.3M | 379,699 | +1.06% |
| Q2 2022 | 2022-06-30 | 36.3M | 392,858 | +1.10% |
| Q1 2022 | 2022-03-31 | 36.1M | 258,293 | +0.72% |
| Q4 2021 | 2021-12-31 | 36.0M | 32.9M | +1061.65% |
| Q3 2021 | 2021-09-30 | 35.9M | — | — |
| Q2 2021 | 2021-06-30 | 35.9M | — | — |
| Q1 2021 | 2021-03-31 | 35.9M | — | — |
| Q4 2020 | 2020-12-31 | 3.1M | — | — |
ImageneBio shares outstanding trends
Across the available reported history, ImageneBio's shares outstanding moved from 48.3M to 48.3M, a change of 0. The latest reported quarter, Q2 2025, shows 48.3M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImageneBio filings at SEC.gov ↗